Overview

Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease

Status:
Completed
Trial end date:
2007-08-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of ramelteon, once daily (QD), in subjects with mild to moderate Alzheimer's Disease and sleep disturbance
Phase:
Phase 2
Details
Lead Sponsor:
Takeda